BioReact
PrivateLast Round
Seed
Feb 12, 2026
Total Funding Raised
$1.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioReact operates in Healthcare & Life Sciences and is based in Indianapolis, Indiana. Its latest recorded funding round was a Seed round in February 2026.
BioReact is a biotechnology software company that provides an AI-powered platform for bioprocess optimization, enabling scientists to automate data alignment, visualize experiments, and predict optimal growth conditions for biopharma, synthetic biology, and industrial biotech applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioReact Comparables
Compare BioReact with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioRaptor | 88% | |
| Invert | 85% | |
| Formical | 84% |
For institutional investors. Book with your work email.
BioReact Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 12, 2026 | ||||
| Pre Seed | Jan 21, 2026 | ||||
| Accelerator | Nov 3, 2024 | ||||
| Seed | Sep 3, 2024 | ||||
| Accelerator | Apr 17, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioReact Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator, Pre Seed, Seed |
| Newstack Ventures | Pre Seed |
| FortySix Capital | Seed |
| gBETA | Accelerator |
| JPMorgan Chase & Co. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 42% month-over-month.
- Feb 12, 2026
Seed round raised from FortySix Capital, hurricaneventures, and The University of Tulsa.
For institutional investors. Book with your work email.
BioReact Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioReact's valuation, stock price, and market status.
Is BioReact a public or private company?
BioReact is a private company.
What is the current stock price of BioReact?
BioReact is a private company, so its shares have no public market price. Caplight tracks BioReact's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioReact worth (valuation)?
Valuation information for BioReact is not publicly available.
Can I buy BioReact stock?
BioReact shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioReact's last funding round?
BioReact's most recent funding round was Seed on February 12, 2026.
Who are the main investors in BioReact?
Key investors in BioReact include Techstars, Newstack Ventures, gBETA.
Will BioReact IPO soon?
No public IPO plans have been announced for BioReact.
How can I track BioReact secondary market activity?
Caplight tracks bids, offers, and trades in BioReact's shares on secondary markets.